{"cord_uid": "0oq4kkn5", "sourcedb": "PMC", "sourceid": "PMC5052702", "divid": "2", "text": "Supplementary Figure 1 : Inhibition of the protease in the FRET - based enzyme activity assay at various concentrations of 1 and 2 in the same ratio as in the ligation assay . Supplementary Figure 2 : The LC chromatogram of the ligation of 1 and 2 in different solvents and with or without enzyme present , clearly shows that multiple outcomes of the ligation process are possible and highly depend on the reaction conditions . Supplementary Figure 12 : 1 H - and 13 C - NMR spectrum of 8 Supplementary Figure 29 : RP - HPLC chromatogram of 21 Supplementary Figure 30 : Deconvoluted ESI - MS spectrum of CVB3 3C Pro HPLC - ESI - MS spectra were recorded with an Agilent 1100 LC / MS system equipped with a Luna - C18 , 3 \u00b5m by Phenomenex . A gradient of water ( solvent A ) and acetonitrile ( solvent B ) was used and each solvent contained 0 . 1 % ( vol / vol ) formic acid . During the analysis the the solvent ratio ( A : B ) was changed from 95 : 5 to 1 : 99 , while maintaining a flowrate of 1 ml / min . Mass spectrometry with 3C Pro - C147A mutant 20 \u00b5L of a 0 . 425 \u00b5g / ml enzyme solution ( containing also 100 mM Tris * HCl , 200 mM NaCl , 4 mM EDTA , 20 % glycerine ) were incubated with 250 \u00b5M inhibitor for 60 minutes .", "project": "cdlai_CORD-19", "denotations": [{"id": "A-biobert_T1", "span": {"begin": 43, "end": 52}, "obj": "Gene"}, {"id": "A-biobert_T2", "span": {"begin": 1033, "end": 1040}, "obj": "Gene"}]}